Page last updated: 2024-11-02

pirenzepine and Cardiovascular Stroke

pirenzepine has been researched along with Cardiovascular Stroke in 3 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Research Excerpts

ExcerptRelevanceReference
"In patients with a recent myocardial infarction, oral pirenzepine proved equal to transdermal scopolamine in significantly increasing indexes of cardiac vagal activity."9.08Effects of oral pirenzepine on heart rate variability and baroreceptor reflex sensitivity after acute myocardial infarction. ( Ballardini, L; Carù, B; Colombo, E; Pedretti, RF; Sarzi Braga, S, 1995)
"Pirenzepine is an atropine analogue approved to treat peptic ulcer disease in Europe that is devoid of central actions, which are mostly responsible for anti-muscarinic agents side effects."5.32Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade. ( Adamson, PB; Foreman, RD; Pedretti, RF; Prete, G; Vanoli, E, 2003)
"In patients with a recent myocardial infarction, oral pirenzepine proved equal to transdermal scopolamine in significantly increasing indexes of cardiac vagal activity."5.08Effects of oral pirenzepine on heart rate variability and baroreceptor reflex sensitivity after acute myocardial infarction. ( Ballardini, L; Carù, B; Colombo, E; Pedretti, RF; Sarzi Braga, S, 1995)
"Pirenzepine is an atropine analogue approved to treat peptic ulcer disease in Europe that is devoid of central actions, which are mostly responsible for anti-muscarinic agents side effects."1.32Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade. ( Adamson, PB; Foreman, RD; Pedretti, RF; Prete, G; Vanoli, E, 2003)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pedretti, RF2
Prete, G1
Foreman, RD1
Adamson, PB1
Vanoli, E1
Colombo, E1
Sarzi Braga, S1
Ballardini, L1
Carù, B1
Engelhardt, D1
Karl, R1
Kolb, HJ1
Inthorn, D1
König, N1
Büll, U1
Hölzel, D1

Trials

2 trials available for pirenzepine and Cardiovascular Stroke

ArticleYear
Effects of oral pirenzepine on heart rate variability and baroreceptor reflex sensitivity after acute myocardial infarction.
    Journal of the American College of Cardiology, 1995, Mar-15, Volume: 25, Issue:4

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Baroreflex; Cross-Over Studies; Heart; Heart

1995
[Comparison between cimetidine-pirenzepine and antacids for the prevention of stress hemorrhage in intensive care patients. A controlled clinical study on 125 patients].
    Deutsche medizinische Wochenschrift (1946), 1985, Jun-07, Volume: 110, Issue:23

    Topics: Adult; Aged; Antacids; Benzodiazepinones; Chromium Radioisotopes; Cimetidine; Clinical Trials as Top

1985

Other Studies

1 other study available for pirenzepine and Cardiovascular Stroke

ArticleYear
Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade.
    Journal of cardiovascular pharmacology, 2003, Volume: 41, Issue:5

    Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Atenolol; Dogs; Dose-Response Relationship, Dru

2003